<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Gastroenterol Rep (Oxf)</journal-id><journal-id journal-id-type="iso-abbrev">Gastroenterol Rep (Oxf)</journal-id><journal-id journal-id-type="publisher-id">gastro</journal-id><journal-id journal-id-type="hwp">gastro</journal-id><journal-title-group><journal-title>Gastroenterology Report</journal-title></journal-title-group><issn pub-type="epub">2052-0034</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27478196</article-id><article-id pub-id-type="pmc">4976685</article-id><article-id pub-id-type="doi">10.1093/gastro/gow023</article-id><article-id pub-id-type="publisher-id">gow023</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Pelvic autonomic nerve preservation in radical rectal cancer surgery: changes in the past 3 decades</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chew</surname><given-names>Min-Hoe</given-names></name><xref ref-type="aff" rid="gow023-AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="gow023-COR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Yeh</surname><given-names>Yu-Ting</given-names></name><xref ref-type="aff" rid="gow023-AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lim</surname><given-names>Evan</given-names></name><xref ref-type="aff" rid="gow023-AFF2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Seow-Choen</surname><given-names>Francis</given-names></name><xref ref-type="aff" rid="gow023-AFF3"><sup>3</sup></xref></contrib><aff id="gow023-AFF1"><sup>1</sup>Department of Colorectal Surgery, Singapore General Hospital, Singapore</aff><aff id="gow023-AFF2"><sup>2</sup>Singhealth Academy, Singapore General Hospital, Singapore</aff><aff id="gow023-AFF3"><sup>3</sup>Seow-Choen Colorectal Centre, Singapore</aff></contrib-group><author-notes><corresp id="gow023-COR1">*<bold>Corresponding author</bold>. Department of Colorectal Surgery, Singapore General Hospital, 20 College Road, Academia, Singapore 169856. Tel: <phone>+65-6321-4677</phone>, Email: <email>chew.min.hoe@singhealth.com.sg</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>31</day><month>7</month><year>2016</year></pub-date><volume>4</volume><issue>3</issue><fpage>173</fpage><lpage>185</lpage><history><date date-type="received"><day>28</day><month>6</month><year>2016</year></date><date date-type="rev-recd"><day>18</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>28</day><month>6</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2016. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-Sen University</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" license-type="creative-commons"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p></license></permissions><abstract><p>The advent of total mesorectal excision (TME) together with minimally invasive techniques such as laparoscopic colorectal surgery and robotic surgery has improved surgical results. However, the incidence of bladder and sexual dysfunction remains high. This may be particularly distressing for the patient and troublesome to manage for the surgeon when it does occur. The increased use of neoadjuvant and adjuvant radiotherapy is also associated with poorer functional outcomes. In this review, we evaluate current understanding of the anatomy of pelvic nerves which are divided into the areas of the inferior mesenteric artery pedicle, the lateral pelvic wall and dissection around the urogenital organs. Surgical techniques in these areas are discussed. We also discuss the results in functional outcomes of the various techniques including open, laparoscopic and robotic over the last 30 years.</p></abstract><kwd-group kwd-group-type="author"><kwd>total mesorectal excision</kwd><kwd>pelvic autonomic nerve preservation</kwd><kwd>urinary dysfunction</kwd><kwd>sexual dysfunction</kwd></kwd-group><counts><page-count count="13"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Surgical management for rectal cancer is challenging due to the narrow pelvis and extreme proximity to contiguous organs; hence, recurrence rates are commonly reported. The advent of total mesorectal excision (TME) [<xref rid="gow023-B1" ref-type="bibr">1</xref>,<xref rid="gow023-B2" ref-type="bibr">2</xref>] together with minimally invasive techniques such as laparoscopic colorectal surgery [<xref rid="gow023-B3" ref-type="bibr">3&#x02013;6</xref>] and robotic surgery [<xref rid="gow023-B7" ref-type="bibr">7&#x02013;9</xref>] have not only improved surgical results but have also improved surgical technique, operative ability and surgical visibility. Nonetheless, the improved survival of patients due surgeons&#x02019; increased ability to resect rectal cancers completely is not without problems. In particular, bladder and sexual dysfunction may be particularly distressing for the patient and troublesome to manage for the surgeon when they do occur.</p><p>The incidence of urinary dysfunction may be as high as 27% and includes difficulty emptying the bladder as well as urinary incontinence. Sexual dysfunction may also reach 11&#x02013;55% after TME. For females, the inability to achieve orgasm, dyspareunia and reduction in vaginal lubrication may be distressing, even for some of the more elderly females. Many male surgeons do not realise that this is an important quality of life factor, especially for younger female patients. For males, nerve dysfunction may include erectile dysfunction, absence of ejaculation or retrograde ejaculation [<xref rid="gow023-B10" ref-type="bibr">10&#x02013;13</xref>]. The increased use of neoadjuvant and adjuvant radiotherapy is associated with poorer functional outcomes. When radiotherapy is indicated, however, it cannot be withheld just because of the fear of nerve dysfunction. One of the main risk factors, poor surgical technique with resultant iatrogenic sexual and urinary dysfunction, however, may be prevented by thorough and practical understanding of pelvic nerve anatomy [<xref rid="gow023-B14" ref-type="bibr">14</xref>].</p><p>This review attempts to evaluate current understanding of the anatomy of pelvic nerves and the differences in outcomes of the various techniques including open, laparoscopic and robotic.</p></sec><sec><title>Surgical Pelvic Nerve Anatomy</title><p>Sexual and urinary dysfunction may be due to somatic and autonomic pelvic nerve damage. The lower pelvis can be divided into 2 anatomical levels: one above the levator ani (supplied by autonomic nerves) and the other below the levator (supplied by somatic innervation via the pudendal nerves) [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B16" ref-type="bibr">16</xref>]. The autonomic plexus includes the superior hypogastric plexus (SHP) comprising sympathetic nerves, the inferior hypogastric plexus (IHP) comprising mixed sympathetic and parasympathetic nerves and the pelvic splanchnic nerves (which are parasympathetic nerves) [<xref rid="gow023-B14" ref-type="bibr">14</xref>,<xref rid="gow023-B15" ref-type="bibr">15</xref>].</p><p>The principles of sharp dissection and direct visualization of all structures during surgery of the rectum apply in all cases regardless of whether open, laparoscopic or robotic techniques are applied. The well-known TME technique requires high ligation of the inferior mesenteric artery pedicle and careful sharp dissection in the &#x02018;holy plane&#x02019; down to the pelvic floor with transection of the rectum (with adequate margins) followed by end-to-end anastomosis. Limitations of direct visualization may result from the anatomical constraints of the narrow bony pelvis, especially with a very curved, prominent sacrum together with a narrow true pelvis which is often especially narrow in the android pelvis. This may be made worse in patients with high body mass index with bulky pelvic sidewall and mesorectal fat. Pelvic adhesions from radiotherapy or tumour inflammation or gross tumour adherence to contiguous organs may also require surgeons to perform extrafascial dissection to achieve good circumferential radial margins or clearance&#x02014;and thereby increase the risk of damage. The possible need for lateral node dissection may also lead to further injury.</p><sec><title>Inferior mesenteric artery (IMA) pedicle</title><sec><title>Nerve anatomy</title><p>The SHP is located anterior to the body of the L5 vertebra and is found on the left anterolateral side of the aorta and its bifurcation [<xref rid="gow023-B15" ref-type="bibr">15</xref>]. The SHP arises from pre-aortic sympathetic trunks alongside the T10&#x02013;L3 vertebrae, descends along the sacral promontory and then bifurcates into the bilateral hypogastric nerves [<xref rid="gow023-B17" ref-type="bibr">17</xref>]. These run 2&#x02009;cm medial to the ureter and common iliac artery on both sides [<xref rid="gow023-B13" ref-type="bibr">13</xref>] (<xref ref-type="fig" rid="gow023-F1">Figure 1</xref>). The hypogastric nerves move obliquely and anteriorly towards the rectum and then along the side of the rectal fascia where they are covered by the endopelvic fascia. These hypogastric nerves finally end as afferent fibres of IHP at the level of the intersection between the vas deferens and the ureter [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B16" ref-type="bibr">16</xref>,<xref rid="gow023-B18" ref-type="bibr">18</xref>].
<fig id="gow023-F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>General overview of anatomy of the autonomic nerve distribution. The superior hypogastric plexus around the inferior mesenteric artery descends to the sacral promnotry and bifurcates into hypogastric nerves. These usually run 1&#x02013;2&#x02009;cm medial to the ureters and cross the common iliac arteries and S1 in the sacrum.</p></caption><graphic xlink:href="gow023f1p"/></fig>
</p></sec><sec><title>Surgical technique</title><p>Ligation of the IMA begins with tenting the sigmoid colon. The promontory and aortic bifurcation are identified, and the surgeon should be aware that the peritoneal layer covering this area holds the hypogastric nerves (<xref ref-type="fig" rid="gow023-F2">Figure 2</xref>). In a medial-to-lateral approach, the incision is made medial to the right iliac vessels and may extend up to the duodenojejuenal flexure. Care is taken to push back the sympathetic pre-aortic nerves together with the retroperitoneal structures, such as the left ureter and left gonadal vessels located just below the peritoneum, using sharp dissection to expose the IMA origin. Technical points:
<list list-type="roman-lower"><list-item><p>Ligation of the IMA should be performed 1.5&#x02013;2&#x02009;cm from its aortic origin to avoid damage to SHP fibres lying in front of the aorta [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B18" ref-type="bibr">18</xref>].</p></list-item><list-item><p>Avoid mass clamping of the IMA which may increase damage to the left trunk of the SHP due to its closer proximity compared with the right trunk of SHP located in the aortocaval plane [<xref rid="gow023-B19" ref-type="bibr">19</xref>].</p></list-item><list-item><p>Preserve Gerota&#x02019;s fascia during mobilisation of the ureter and gonadal vessels as these contain SHP fibres [<xref rid="gow023-B20" ref-type="bibr">20</xref>].</p></list-item><list-item><p>At the level of the sacral promontory, the transition from mesosigmoid to mesorectum is an area where damage is possible to the presacral plexus and hypogastric nerves. To avoid the wrong plane of dissection, it is important to dissect only immediately posterior to the superior rectal artery and to remain within the plane anterior to the parietal presacral fascia. It has been suggested that this should be approximately 2&#x02009;cm anterior to the promontory [<xref rid="gow023-B20" ref-type="bibr">20</xref>,<xref rid="gow023-B21" ref-type="bibr">21</xref>].</p></list-item></list>
<fig id="gow023-F2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Inferior hypogastric nerve with branches to the rectum on a robotic view with medial-to-lateral dissection approach.</p></caption><graphic xlink:href="gow023f2p"/></fig>
</p></sec></sec><sec><title>Lateral pelvic wall</title><sec><title>Nerve anatomy</title><p>The IHP receives pelvic parasympathetic fibres from roots S2&#x02013;S5 (splanchnic nerves or erector nerves of Eckard). These nerves are covered by the parietal fascia, pierce the endopelvic fascia, cross the retrorectal space and form branches into the rectum via the lateral ligaments [<xref rid="gow023-B15" ref-type="bibr">15</xref>]. Fibres from the IHP also innervate the seminal vesicles, prostate and bladder, cervix and vagina. These nerves are responsible for penile erection, detrusor contractility, female arousal and vaginal lubrication. The pelvic parasympathetic nerves join the sympathetic hypogastric nerves in a Y-shaped connection to form the pelvic plexus (<xref ref-type="fig" rid="gow023-F3">Figure 3</xref>).
<fig id="gow023-F3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Anatomy of the pelvic autonomic nerves with relation to rectum. The inferior hypogastric plexus comprises nerves from the hypogastric and pelvic splanchnic nerves at lateral pelvic wall.</p></caption><graphic xlink:href="gow023f3p"/></fig>
</p><p>The lateral ligaments are thought to be a condensation of endopelvic connective tissue located on the anterolateral side of the subperitoneal rectum. Some authors suggest that &#x02018;lateral ligaments&#x02019; do not exist and are not distinct anatomical structures; instead, these ligaments are perhaps an artefact produced by surgical dissection. These ligaments may or may not contain an insignificant or small middle rectal artery [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B16" ref-type="bibr">16</xref>,<xref rid="gow023-B22" ref-type="bibr">22</xref>]. Other authors suggest that the lateral ligaments join the parietal fascia to the fascia propia and that part of the IHP lies within the lateral ligaments, giving branches to the rectum. These arise bilaterally about 2&#x02009;cm below the peritoneal reflection [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B23" ref-type="bibr">23</xref>]. Others, however, suggest that all lymphatics are located within the mesorectum and are arranged around the superior rectal artery with no lymphatic drainage into the lateral ligaments [<xref rid="gow023-B24" ref-type="bibr">24</xref>].</p></sec><sec><title>Surgical technique</title><p>The opinion that anatomic dissection of the rectum does not require over-zealous lateral dissection arose from this latter understanding. Dissection of the lateral ligaments is best done after posterior dissection has gone as far down to the pelvic floor as possible. [<xref rid="gow023-B16" ref-type="bibr">16</xref>] With adequate traction and countertraction, the hypogastric nerves can be visualised as they enter the deep layers of the parietal fascia to the IHP. It is suggested that the adherent nerves can be eased off the mesorectal fascia laterally. The surgeon should avoid hooking the tissue laterally with the finger; neither should there be a need to cross-clamp the middle rectal pedicle to avoid damaging the nerves [<xref rid="gow023-B25" ref-type="bibr">25</xref>,<xref rid="gow023-B26" ref-type="bibr">26</xref>].</p></sec></sec><sec><title>Dissection around urogenital organs</title><sec><title>Nerve anatomy</title><p>The pelvic plexus is a network of nerves, located at the level of the lower third of the rectum, that innervate the rectum, bladder, seminal vesicles, prostate, ureters, membranous urethra, corpora cavernosa, uterus and vagina [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B21" ref-type="bibr">21</xref>]. In men, neurovascular bundles (of Walsh) from the pelvic plexus include the cavernous nerves which are responsible for erectile function and run laterally outside Denonvilliers fascia, lie at the lateral corners of the seminal vesicles at the 2 and 10 o&#x02019;clock positions and eventually lie anterior to the postero-lateral border of the prostate and continue onto the periprostatic plexus [<xref rid="gow023-B25" ref-type="bibr">25</xref>]. In women, the nerves enter the vesicovaginal and rectovaginal septa and run underneath the crossing point of the ureter and uterine artery [<xref rid="gow023-B21" ref-type="bibr">21</xref>].</p></sec><sec><title>Surgical technique</title><p>Dissection of the infra-peritoneal rectum from the prostate, seminal vesicles and vagina which are areas at high risk of nerve injury [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B21" ref-type="bibr">21</xref>]. Heald <italic>et&#x000a0;al</italic> in their original technique considered that the Denonvilliers fascia should be resected in TME surgery as it forms the anterior surface of the mesorectum [<xref rid="gow023-B2" ref-type="bibr">2</xref>]. It is however suggested that this extra-mesorectal resection should only be performed if there are concerns about a compromised circumferential resection margin, especially for anterior-based tumours. In such a case, care during dissection should be taken along all dissection planes within the propria fascia of the rectum. Once below the rectoprostatic fascia, the correct plane is along the muscular wall of the rectum [<xref rid="gow023-B15" ref-type="bibr">15</xref>,<xref rid="gow023-B26" ref-type="bibr">26</xref>,<xref rid="gow023-B27" ref-type="bibr">27</xref>]. For posterior and lateral rectal tumours, it is suggested that the entire rectoprostatic fascia be left intact [<xref rid="gow023-B28" ref-type="bibr">28</xref>] (<xref ref-type="fig" rid="gow023-F4">Figure 4</xref>). There are, however, additional difficulties in identifying Denonvilliers fascia in elderly patients following neoadjuvant radiotherapy or in those patients with a narrow bony pelvis or very large bulky tumours.
<fig id="gow023-F4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>The relationship of the rectum and pelvic autonomic nerves during open surgery when standing on the patient&#x02019;s left. The ligation of the inferior mesenteric artery should be performed 1.5&#x02013;2&#x02009;cm from its origin from the aorta to avoid damaging the superior hypogastric plexus. At the pelvis, for posterior and lateral tumours, dissection should be directed below the Denonvillliers fascia to avoid damaging the neurovascular bundles that run along the tip of the seminal vesicle (2 and 10 o&#x02019;clock directions).</p></caption><graphic xlink:href="gow023f4p"/></fig>
</p><p>During the perineal phase of an abdominoperineal resection, care should be taken especially at the level of the prostate which contains the dorsal nerve of the penis and plays an important role in erection and ejaculation [<xref rid="gow023-B13" ref-type="bibr">13</xref>,<xref rid="gow023-B29" ref-type="bibr">29</xref>]. This is commonly damaged during excessive traction or excessive or prolonged cautery in the anterolateral plane of dissection.</p></sec></sec></sec><sec><title>Comparison of Functional Outcomes with Regards to Open, Laparoscopic and Robotic TME</title><p>The introduction of TME was important not only for reducing local recurrence but also for preserving urogenital function [<xref rid="gow023-B2" ref-type="bibr">2</xref>]. The emphasis on sharp pelvic dissection in anatomical planes of the pelvis must be obeyed regardless if the technique is open, laparoscopic or robotic TME. However, postoperative sexual and urinary dysfunction occurs due to inadvertent avulsion or direct injury of nerve plexus.</p><p>Laparoscopic rectal surgery is technically difficult, and advanced laparoscopic surgical skills are required. As technology has improved over the years and high-definition cameras replaced traditional optic lenses and reduced &#x02018;smoky&#x02019; images due to use of energy devices, the advances in dissection have produced convincing evidence of short-term benefits of reduced pain, shorter hospital stays and earlier returns to normal work without compromising oncology outcomes. Energy devices, however, produce more heat laterally in contrast to electrocautery, and initial concerns were increased risk of nerve damage.</p><p>Certain limitations continue to plague laparoscopic surgery, however, particularly the use of unarticulated rigid instruments. A good assistant is especially important during TME because two-dimensional view and poor ergonomics can negatively impact any surgeon attempting to visualize nerves during rectal dissection. The marked interest in robotic surgery was largely due to several reasons: (a) the EndoWrist function with seven degrees of freedom; (b) the magnified view of the operative field; (c) the decrease of inherent operator tremor and (d) the precision of instruments was said to be associated with improved functional outcomes. Next, we review the current published literature and compare the outcomes with respect to the different techniques of rectal surgery.</p><sec><title>Urinary dysfunction</title><p>The studies of open TME are largely cohort studies. In older studies between the years1990 and 2002, the median follow-up ranged from 3 to 41 months, and the number of study subjects ranged from 68 to 199 patients (<xref ref-type="table" rid="gow023-T1">Table 1</xref>) [<xref rid="gow023-B11" ref-type="bibr">11</xref>,<xref rid="gow023-B12" ref-type="bibr">12</xref>,<xref rid="gow023-B30" ref-type="bibr">30&#x02013;36</xref>]. While reporting incidences and outcomes varied with different classifications, the overall incidence can be as high as 33%. When non-conventional TME was performed, 19% <italic>vs</italic> 7% of subjects who underwent standard TME had increased difficulty in voiding [<xref rid="gow023-B35" ref-type="bibr">35</xref>,<xref rid="gow023-B36" ref-type="bibr">36</xref>].
<table-wrap id="gow023-T1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Incidence of urinary dysfunction when comparing open, laparoscopic and robotic total mesorectal excision (TME)</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Literature</th><th rowspan="1" colspan="1">Year of publication</th><th rowspan="1" colspan="1">Study design</th><th rowspan="1" colspan="1">Procedure type</th><th rowspan="1" colspan="1">Subjects evaluated</th><th rowspan="1" colspan="1">Duration of follow-up (months)</th><th rowspan="1" colspan="1">Complications</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><bold>Open TME</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Hojo <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B30" ref-type="bibr">30</xref>]</td><td rowspan="1" colspan="1">1990</td><td rowspan="1" colspan="1">Case series - Retrospective</td><td rowspan="1" colspan="1">TME and ANP</td><td rowspan="1" colspan="1">134</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Multi-level sacrifice of HP and PP contributes to more severe urinary dysfunction and increasing bladder hypertonia</td></tr><tr><td rowspan="1" colspan="1">Havenga <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B29" ref-type="bibr">29</xref>]</td><td rowspan="1" colspan="1">1996</td><td rowspan="1" colspan="1">Case series - Retrospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">136</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No significant change in both male and female urinary function</td></tr><tr><td rowspan="1" colspan="1">Sugihara <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B31" ref-type="bibr">31</xref>]</td><td rowspan="1" colspan="1">1996</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME and ANP</td><td rowspan="1" colspan="1">199</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>Urinary dysfunction:</p></list-item><list-item><p>&#x02003;0% in intact HP and PP</p></list-item><list-item><p>&#x02003;3.9% in sacrifice HP and intact bilateral PP</p></list-item><list-item><p>&#x02003;6.5% in sacrifice HP and unilateral PP</p></list-item><list-item><p>&#x02003;30.8% in complete resection of pelvic autonomic nerves</p></list-item></list></td></tr><tr><td rowspan="1" colspan="1">Saito <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B32" ref-type="bibr">32</xref>]</td><td rowspan="1" colspan="1">1998</td><td rowspan="1" colspan="1">Case series</td><td rowspan="1" colspan="1">TME and ANP</td><td rowspan="1" colspan="1">167</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No requirement for long-term indwelling catheter</td></tr><tr><td rowspan="1" colspan="1">Ishikura <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B33" ref-type="bibr">33</xref>]</td><td rowspan="1" colspan="1">1999</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME and ANP with PLND</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">Median 41</td><td rowspan="1" colspan="1">Urinary dysfunction in both sexes: 18.4%</td></tr><tr><td rowspan="1" colspan="1">Maas <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B35" ref-type="bibr">35</xref>]</td><td rowspan="1" colspan="1">2000</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME and ANP with radical rectal resection</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">Median 42</td><td rowspan="1" colspan="1">Urinary frequency in both sexes: 22%;</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Minor incontinence in both sexes: 19%</td></tr><tr><td rowspan="1" colspan="1">Nesbakken <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B34" ref-type="bibr">34</xref>]</td><td rowspan="1" colspan="1">2000</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">No significant change in urinary symptom score (both sexes) except for increase in female incontinence score</td></tr><tr><td rowspan="1" colspan="1">Maurer <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B36" ref-type="bibr">36</xref>]</td><td rowspan="1" colspan="1">2001</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">TME <italic>vs</italic> Non-TME conventional rectal excision</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">Minimum 3</td><td rowspan="1" colspan="1">No significant change in urinary symptom among both groups</td></tr><tr><td rowspan="1" colspan="1">Pocard <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B12" ref-type="bibr">12</xref>]</td><td rowspan="1" colspan="1">2002</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">Up to 60</td><td rowspan="1" colspan="1">Both sexes requiring indwelling catheter: 0%.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No significant change in urinary symptom score (both sexes).</td></tr><tr><td rowspan="1" colspan="1">Kim <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B11" ref-type="bibr">11</xref>]</td><td rowspan="1" colspan="1">2002</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">Median 8.7</td><td rowspan="1" colspan="1">Males requiring long-term indwelling catheter: 0%.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No significant change of male IPSS score.</td></tr><tr><td rowspan="1" colspan="1">Junginger <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B38" ref-type="bibr">38</xref>]</td><td rowspan="1" colspan="1">2003</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME with pelvic plexus visualisation</td><td rowspan="1" colspan="1">150</td><td rowspan="1" colspan="1">Median 24</td><td rowspan="1" colspan="1">Overall urinary dysfunction (both sexes): 12%.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Complete or partially visualised ANP 4.5% <italic>vs</italic> non-visualised: 38.5%.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Required short-term indwelling catheter (both sexes) : 10.7%.</td></tr><tr><td rowspan="1" colspan="1">Kneist <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B37" ref-type="bibr">37</xref>]</td><td rowspan="1" colspan="1">2004</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">TME or partial mesorectal excision</td><td rowspan="1" colspan="1">229</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Overall urinary dysfunction (both sexes): 4.1% with complete ANP <italic>vs</italic> 22.4% without ANP.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Both sexes long-term indwelling catheter 8.8%.</td></tr><tr><td rowspan="1" colspan="1">Shirouzu <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B40" ref-type="bibr">40</xref>]</td><td rowspan="1" colspan="1">2004</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">TME with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">292</td><td rowspan="1" colspan="1">Median 218</td><td rowspan="1" colspan="1">Overall urinary dysfunction (both sexes):&#x000a0;&#x0003c; 20% with complete ANP <italic>vs</italic>&#x000a0;&#x0003e; 90% without ANP</td></tr><tr><td rowspan="1" colspan="1">Sterk <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B39" ref-type="bibr">39</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">Urinary dysfunction (both sexes): 24.4% at 14 days and 8.1% at 3 months</td></tr><tr><td rowspan="1" colspan="1">Wang <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B45" ref-type="bibr">45</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female urinary dysfunction: 6.25% with ANP <italic>vs</italic> 31.25% without ANP (SD).</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Residual urine&#x02009;&#x0003e;&#x02009;50&#x02009;ml: 10.41% with ANP <italic>vs</italic> 31.25% without ANP.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Significantly longer duration to recover from urinary symptoms in patients without ANP.</td></tr><tr><td rowspan="1" colspan="1">Laing <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B46" ref-type="bibr">46</xref>]</td><td rowspan="1" colspan="1">2006</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">236</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Overall male urinary dysfunction: 12.71% with ANP <italic>vs</italic> 70.33% without ANP (SD only occurred in Duke A and Duke B comparative groups)</td></tr><tr><td rowspan="1" colspan="1">Kyo <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B41" ref-type="bibr">41</xref>]</td><td rowspan="1" colspan="1">2006</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME and ANP with <italic>vs</italic> without PLND</td><td rowspan="1" colspan="1">37</td><td rowspan="1" colspan="1">Minimum 7</td><td rowspan="1" colspan="1">Male urinary dysfunction: 33% with PLND <italic>vs</italic> 9.5% without PLND</td></tr><tr><td rowspan="1" colspan="1">Dong <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B47" ref-type="bibr">47</xref>]</td><td rowspan="1" colspan="1">2007</td><td rowspan="1" colspan="1">Case series - Retrospective</td><td rowspan="1" colspan="1">Open TME with ANP</td><td rowspan="1" colspan="1">124</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Failed urinary catheter removal on post-op day 3: 9.7%</td></tr><tr><td rowspan="1" colspan="1">Kneist <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B42" ref-type="bibr">42</xref>]</td><td rowspan="1" colspan="1">2007</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Open TME, operative bladder neurophysiology monitor with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">62</td><td rowspan="1" colspan="1">Median 20</td><td rowspan="1" colspan="1">Urinary dysfunction (both sexes): 2.1% with complete ANP <italic>vs</italic> 60% without ANP.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Both sexes required long-term indwelling catheter: 2.1% with ANP <italic>vs</italic> 33.3% without ANP.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Significantly worse in urinary symptom score without ANP.</td></tr><tr><td rowspan="1" colspan="1">Akasu <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B43" ref-type="bibr">43</xref>]</td><td rowspan="1" colspan="1">2009</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">LAR/APR with selected ANP and PLND</td><td rowspan="1" colspan="1">69</td><td rowspan="1" colspan="1">0.5</td><td rowspan="1" colspan="1">Residual urine&#x02009;&#x0003e;&#x02009;50&#x02009;ml at day 14 (SD)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bilateral pelvic-plexus preservation without PLND: 4%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bilateral pelvic-plexus preservation with PLND: 27%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Unilateral pelvic-plexus preservation with PLND: 76%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No pelvic-plexus preservation with PLND: 100%</td></tr><tr><td rowspan="1" colspan="1">Zhao <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B48" ref-type="bibr">48</xref>]</td><td rowspan="1" colspan="1">2011</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME and ANP <italic>vs</italic> TME alone</td><td rowspan="1" colspan="1">84</td><td rowspan="1" colspan="1">Up to 24</td><td rowspan="1" colspan="1">Male urinary dysfunction: 24.4% in TME and ANP <italic>vs</italic> 79.1% in TME alone (SD)</td></tr><tr><td rowspan="1" colspan="1">Cakabay <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B44" ref-type="bibr">44</xref>]</td><td rowspan="1" colspan="1">2012</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male urinary dysfunction: 25%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male requiring long-term indwelling catheter: 5%</td></tr><tr><td rowspan="1" colspan="1"><bold>Laparoscopic/robotic TME</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Quah <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B10" ref-type="bibr">10</xref>]</td><td rowspan="1" colspan="1">2002</td><td rowspan="1" colspan="1">Randomized controlled trial</td><td rowspan="1" colspan="1">Laparoscopic assisted <italic>vs</italic> open TME</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">Median 36</td><td rowspan="1" colspan="1">Urinary dysfunction (both sexes): 0%.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Males required long-term indwelling catheter: 2.5% in laparoscopic <italic>vs</italic> 0% in open (no SD).</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Females required long-term indwelling catheter: 2.5% in laparoscopic <italic>vs</italic> 0% in open (no SD).</td></tr><tr><td rowspan="1" colspan="1">Jayne <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B49" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Randomized controlled trial</td><td rowspan="1" colspan="1">Laparoscopic colonic <italic>vs</italic> open rectal <italic>vs</italic> laparoscopic rectal</td><td rowspan="1" colspan="1">246</td><td rowspan="1" colspan="1">Up to 76</td><td rowspan="1" colspan="1">Urinary dysfunction (both sexes): 21% in laparoscopic colonic, 35% in open/laparoscopic rectal.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No significant change in urinary symptom score after 6 months.</td></tr><tr><td rowspan="1" colspan="1">Liang <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B52" ref-type="bibr">52</xref>]</td><td rowspan="1" colspan="1">2007</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">Laparoscopic TME</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">Minimum 3</td><td rowspan="1" colspan="1">Urinary dysfunction (both sexes): 17.6%</td></tr><tr><td rowspan="1" colspan="1">Kim <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B54" ref-type="bibr">54</xref>]</td><td rowspan="1" colspan="1">2012</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> robotic TME</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Urinary dysfunction (both sexes): 3.3% in robotic <italic>vs</italic> 5.1% in Lap (no SD)</td></tr><tr><td rowspan="1" colspan="1">McGloen <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">2012</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">laparoscopic <italic>vs</italic> open TME</td><td rowspan="1" colspan="1">143</td><td rowspan="1" colspan="1">Minimum 6</td><td rowspan="1" colspan="1">No significant change in urinary symptom score (both sexes)</td></tr><tr><td rowspan="1" colspan="1">D&#x02019;Annibale <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B55" ref-type="bibr">55</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> robotic TME</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male urinary dysfunction: 0%</td></tr><tr><td rowspan="1" colspan="1">Runkel <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B53" ref-type="bibr">53</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">Laparoscopic nerve orientated mesorectal excision</td><td rowspan="1" colspan="1">274</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male requiring long-term indwelling catheter: 0.5%</td></tr><tr><td rowspan="1" colspan="1">Luca <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B57" ref-type="bibr">57</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">Totally robotic TME</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">17.03</td><td rowspan="1" colspan="1">Male urinary dysfunction: 0%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female urinary dysfunction: 0%</td></tr><tr><td rowspan="1" colspan="1">Hur <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Non-randomized control trial</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> open TME</td><td rowspan="1" colspan="1">97</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Urinary dysfunction (both sexes): 5.4% in laparoscopic <italic>vs</italic> 7.3% in open (no SD).</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Required long-term indwelling catheter (both sexes): 0%.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No significant changes in IPSS score between both groups.</td></tr><tr><td rowspan="1" colspan="1">Zeng <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B59" ref-type="bibr">59</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> open TME with ANP</td><td rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Overall male urinary dysfunction: 16.28% in laparoscopic <italic>vs</italic> 15.79% in open (no SD)</td></tr><tr><td rowspan="1" colspan="1">Park <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B56" ref-type="bibr">56</xref>]</td><td rowspan="1" colspan="1">2014</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Laparoscopy <italic>vs</italic> Robotic TME</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">No difference in IPSS scores</td></tr></tbody></table><table-wrap-foot><fn id="gow023-TF1"><p>ANP: autonomic nerve preservation; PLND: pelvic lymph node dissection; IPSS: International Prostate Symptom Score; SD: statistical significant difference; HP: Hypogastric plexus; PP: Pelvic Plexus</p></fn></table-wrap-foot></table-wrap></p><p>In newer studies between the years 2003 and 2013, the median follow-up ranged from 7 to 218 months (<xref ref-type="table" rid="gow023-T1">Table 1</xref>) [<xref rid="gow023-B37" ref-type="bibr">37&#x02013;48</xref>]. The number of study subjects ranged from 20 to 292 patients, although 3 studies were performed at the same study center [<xref rid="gow023-B37" ref-type="bibr">37</xref>,<xref rid="gow023-B38" ref-type="bibr">38</xref>,<xref rid="gow023-B42" ref-type="bibr">42</xref>]. When autonomic nerve preservation (ANP) was practiced, the incidence of urinary dysfunction ranged from 2.1 to 24.4% [<xref rid="gow023-B37" ref-type="bibr">37&#x02013;41</xref>,<xref rid="gow023-B45" ref-type="bibr">45&#x02013;48</xref>]. This was significantly higher (between 22.4 and 79.1%) if ANP was not observed during surgery [<xref rid="gow023-B37" ref-type="bibr">37</xref>,<xref rid="gow023-B38" ref-type="bibr">38</xref>,<xref rid="gow023-B42" ref-type="bibr">42</xref>,<xref rid="gow023-B45" ref-type="bibr">45&#x02013;48</xref>]. Long-term indwelling catheter use was 2.1&#x02013;10.8% with ANP, but 30&#x02013;40% of these patients had successful trial of void within 6 months and improvement of function [<xref rid="gow023-B37" ref-type="bibr">37</xref>,<xref rid="gow023-B38" ref-type="bibr">38</xref>,<xref rid="gow023-B42" ref-type="bibr">42</xref>]. In patients who had pelvic lymph node dissection (PLND), the incidence in these studies noted a high rate of urinary dysfunction [<xref rid="gow023-B32" ref-type="bibr">32</xref>,<xref rid="gow023-B41" ref-type="bibr">41</xref>,<xref rid="gow023-B43" ref-type="bibr">43</xref>], and patients may take 2&#x02013;3 weeks to return to presurgical residual urinary volume [<xref rid="gow023-B42" ref-type="bibr">42</xref>].</p><p>For laparoscopic TME, there were 2 randomized controlled trials comparing laparoscopic <italic>vs</italic> open TME techniques which reported functional outcomes [<xref rid="gow023-B10" ref-type="bibr">10</xref>,<xref rid="gow023-B49" ref-type="bibr">49</xref>]. While function was not the primary endpoint, there were no significant overall differences in urinary function between the laparoscopic and TME groups. This finding was also supported by other recent cohort studies (<xref ref-type="table" rid="gow023-T1">Table 1</xref>) [<xref rid="gow023-B50" ref-type="bibr">50&#x02013;53</xref>,<xref rid="gow023-B59" ref-type="bibr">59</xref>]. Of note, Jayne <italic>et&#x000a0;al<italic>.</italic></italic> and Hur <italic>et&#x000a0;al<italic>.</italic></italic> reported that voiding function would reduce after surgery with some restoration by 6 months and full recovery to preoperative levels by 12 months [<xref rid="gow023-B49" ref-type="bibr">49</xref>,<xref rid="gow023-B51" ref-type="bibr">51</xref>]. The incidence of minor urinary dysfunction was low regardless of technique (7.3% open TME <italic>vs</italic> 5.4% laparoscopic TME) [<xref rid="gow023-B50" ref-type="bibr">50</xref>]. When laparoscopic TME was compared with robotic TME, Kim <italic>et&#x000a0;al<italic>.</italic></italic> noted that restoration of urinary function was faster at 3 months [<xref rid="gow023-B54" ref-type="bibr">54</xref>]. There are, however, no differences seen in bladder function between the 2 groups 12 months after surgery in other studies as well [<xref rid="gow023-B55" ref-type="bibr">55&#x02013;58</xref>]. In all studies the incidence of permanent IDC was very low at 0.5%.</p></sec></sec><sec><title>Sexual dysfunction</title><p>For open TME studies, the incidence of sexual dysfunction ranges from 11% to 85%. If ANP is performed, the incidence of male erectile dysfunction ranges from 1.5% to 49.15%, and the incidence of male ejaculatory dysfunction ranges from 12% to 44.2% (<xref ref-type="table" rid="gow023-T2">Table 2</xref>) [<xref rid="gow023-B11" ref-type="bibr">11</xref>,<xref rid="gow023-B12" ref-type="bibr">12</xref>,<xref rid="gow023-B29" ref-type="bibr">29&#x02013;36</xref>,<xref rid="gow023-B39" ref-type="bibr">39&#x02013;41</xref>,<xref rid="gow023-B43" ref-type="bibr">43&#x02013;48</xref>,<xref rid="gow023-B58" ref-type="bibr">58</xref>,<xref rid="gow023-B60" ref-type="bibr">60&#x02013;62</xref>]. There were, however, 2 older studies that noted a very high incidence of erectile dysfunction (69%) and ejaculatory dysfunction (85%) even with ANP [<xref rid="gow023-B30" ref-type="bibr">30</xref>,<xref rid="gow023-B32" ref-type="bibr">32</xref>]. If ANP is not performed, the incidence can be as high as 100% [<xref rid="gow023-B40" ref-type="bibr">40</xref>]. Only a few studies have reported female sexual dysfunction (due to low questionnaire response rate of female candidates compared with male counterparts). The incidence of orgasmic dysfunction reported in females is significantly lower at 0 to 10.5% [<xref rid="gow023-B12" ref-type="bibr">12</xref>,<xref rid="gow023-B34" ref-type="bibr">34</xref>,<xref rid="gow023-B35" ref-type="bibr">35</xref>,<xref rid="gow023-B45" ref-type="bibr">45</xref>,<xref rid="gow023-B58" ref-type="bibr">58</xref>], with only 2 studies reporting incidence of dyspareunia ranging from 4.15% to 66.7% [<xref rid="gow023-B35" ref-type="bibr">35</xref>,<xref rid="gow023-B45" ref-type="bibr">45</xref>]. If pelvic lymph node dissection is performed, the incidence of dysfunction can range from 21.5% to as high as 90% [<xref rid="gow023-B33" ref-type="bibr">33</xref>,<xref rid="gow023-B41" ref-type="bibr">41</xref>].
<table-wrap id="gow023-T2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Incidence of sexual dysfunction when comparing open, laparoscopic and robotic total mesorectal excision (TME)</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Literature</th><th rowspan="1" colspan="1">Year of publication</th><th rowspan="1" colspan="1">Study design</th><th rowspan="1" colspan="1">Procedure type</th><th rowspan="1" colspan="1">Subjects evaluated</th><th rowspan="1" colspan="1">Duration of follow-up (months)</th><th rowspan="1" colspan="1">Complications</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><bold>Open TME</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Hojo <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B30" ref-type="bibr">30</xref>]</td><td rowspan="1" colspan="1">1990</td><td rowspan="1" colspan="1">Case series - Retrospective</td><td rowspan="1" colspan="1">TME and ANP</td><td rowspan="1" colspan="1">39</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male erectile dysfunction: 69%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 85%</td></tr><tr><td rowspan="1" colspan="1">Havenga <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B29" ref-type="bibr">29</xref>]</td><td rowspan="1" colspan="1">1996</td><td rowspan="1" colspan="1">Case series - Retrospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">136</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 13%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x0003c;&#x000a0;60 year-old sexual dysfunction (both sexes): 14%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">&#x0003e; 60 year-old sexual dysfunction (both sexes): 33%</td></tr><tr><td rowspan="1" colspan="1">Sugihara <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B31" ref-type="bibr">31</xref>]</td><td rowspan="1" colspan="1">1996</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME and ANP</td><td rowspan="1" colspan="1">57</td><td rowspan="1" colspan="1">Median 53</td><td rowspan="1" colspan="1">Male sexual dysfunction with and without ANP: 66.7%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male sexual dysfunction with complete ANP: 29.6%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile dysfunction with complete ANP: 3.8%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile dysfunction with incomplete ANP: 20%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction with complete ANP: 18.5%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction with incomplete ANP: 100%</td></tr><tr><td rowspan="1" colspan="1">Enker <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B58" ref-type="bibr">58</xref>]</td><td rowspan="1" colspan="1">1997</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">TME and ANP in APR <italic>vs</italic> LAR</td><td rowspan="1" colspan="1">136</td><td rowspan="1" colspan="1">up to 60</td><td rowspan="1" colspan="1">Male sexual dysfunction in LAR: 14%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male sexual dysfunction in APR: 43%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction in LAR: 12%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction in APR: 15%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female sexual dysfunction: 14%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female orgasmic dysfunction: 9%</td></tr><tr><td rowspan="1" colspan="1">Saito <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B32" ref-type="bibr">32</xref>]</td><td rowspan="1" colspan="1">1998</td><td rowspan="1" colspan="1">Case series</td><td rowspan="1" colspan="1">TME and ANP</td><td rowspan="1" colspan="1">167</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Unsuccessful in preserving sexual function</td></tr><tr><td rowspan="1" colspan="1">Ishikura <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B33" ref-type="bibr">33</xref>]</td><td rowspan="1" colspan="1">1999</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME and ANP with PLND</td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">Median 41</td><td rowspan="1" colspan="1">Male sexual dysfunction: 21.5%</td></tr><tr><td rowspan="1" colspan="1">Maas <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B35" ref-type="bibr">35</xref>]</td><td rowspan="1" colspan="1">2000</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME and ANP with radical rectal resection</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">Median 42</td><td rowspan="1" colspan="1">Male erectile dysfunction 8.3% with preserved SHP and 100% without complete preservation of ANP.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction 12.5% with preserved SHP and 100% with sacrifice of SHP.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female dyspareunia: 66.7%</td></tr><tr><td rowspan="1" colspan="1">Nesbakken <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B34" ref-type="bibr">34</xref>]</td><td rowspan="1" colspan="1">2000</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Male erectile dysfunction: 16.7%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 7.6%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female orgasmic dysfunction: 0%</td></tr><tr><td rowspan="1" colspan="1">Maurer <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B36" ref-type="bibr">36</xref>]</td><td rowspan="1" colspan="1">2001</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">TME <italic>vs</italic> Non-TME Conventional Rectal Excision</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">Minimum 3</td><td rowspan="1" colspan="1">Male sexual dysfunction increased from 33% preop to 93% postop in conventional group <italic>vs</italic> from 47% to 78% in TME group.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile dysfunction increased from 25% preop to 94% postop in conventional group <italic>vs</italic> from 42% to 74% in TME group.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction increased from 12% preop to 91% postop in conventional group <italic>vs</italic> from 24% to 47% in TME group</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Insufficient data for female sexual dysfunction analysis</td></tr><tr><td rowspan="1" colspan="1">Kim <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B11" ref-type="bibr">11</xref>]</td><td rowspan="1" colspan="1">2002</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">68</td><td rowspan="1" colspan="1">Median 8.7</td><td rowspan="1" colspan="1">Male erectile dysfunction: 19.1%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 13.2%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Significant worsening of IIEF Score in all domains</td></tr><tr><td rowspan="1" colspan="1">Pocard <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B12" ref-type="bibr">12</xref>]</td><td rowspan="1" colspan="1">2002</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">Up to 36</td><td rowspan="1" colspan="1">Male erectile dysfunction: 0%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 11.0%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female orgasmic dysfunction: 0%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female dyspareunia: 0%</td></tr><tr><td rowspan="1" colspan="1">Wang <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B60" ref-type="bibr">60</xref>]</td><td rowspan="1" colspan="1">2003</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">104</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile dysfunction: 32.7% with ANP <italic>vs</italic> 63.5% without ANP (SD).</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 44.2% with ANP <italic>vs</italic> 71.2% without ANP (SD)</td></tr><tr><td rowspan="1" colspan="1">Shirouzu <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B40" ref-type="bibr">40</xref>]</td><td rowspan="1" colspan="1">2004</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">TME with ANP <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">129</td><td rowspan="1" colspan="1">Median 218</td><td rowspan="1" colspan="1">Male erectile dysfunction: 21% with ANP <italic>vs</italic> 100% without ANP.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 35% with ANP <italic>vs</italic> 100% without ANP</td></tr><tr><td rowspan="1" colspan="1">Sterk <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B39" ref-type="bibr">39</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Case series - prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">29</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">Male erectile dysfunction: 55.1%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 3.6%</td></tr><tr><td rowspan="1" colspan="1">Wang <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B61" ref-type="bibr">61</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Case series - Retrospective</td><td rowspan="1" colspan="1">Open TME</td><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male sexual dysfunction: 35.2%</td></tr><tr><td rowspan="1" colspan="1">Wang <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B62" ref-type="bibr">62</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">105</td><td rowspan="1" colspan="1">Up to 84</td><td rowspan="1" colspan="1">Male erectile dysfunction: 33.3% with ANP <italic>vs</italic> 63.2% without ANP (SD)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 43.8% with ANP <italic>vs</italic> 70.0% without ANP (SD)</td></tr><tr><td rowspan="1" colspan="1">Wang <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B45" ref-type="bibr">45</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female dyspareunia: 4.15% with ANP <italic>vs</italic> 37.5% without ANP (SD)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female orgasmic dysfunction: 10.5% with ANP <italic>vs</italic> 45.9% without ANP (SD)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female sexual arousal dysfunction: 12.5% with ANP <italic>vs</italic> 54.16% without ANP</td></tr><tr><td rowspan="1" colspan="1">Laing <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B46" ref-type="bibr">46</xref>]</td><td rowspan="1" colspan="1">2006</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME with <italic>vs</italic> without ANP</td><td rowspan="1" colspan="1">236</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Overall Male erectile dysfunction: 49.15% with ANP <italic>vs</italic> 95.76% without ANP (SD)</td></tr><tr><td rowspan="1" colspan="1">Kyo <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B41" ref-type="bibr">41</xref>]</td><td rowspan="1" colspan="1">2006</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">TME and ANP with <italic>vs</italic> without PLND</td><td rowspan="1" colspan="1">30</td><td rowspan="1" colspan="1">Minimum 7</td><td rowspan="1" colspan="1">Male erectile dysfunction: 50% with PLND <italic>vs</italic> 10% without PLND (no SD)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 90% with PLND <italic>vs</italic> 30% without PLND (SD)</td></tr><tr><td rowspan="1" colspan="1">Dong <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B47" ref-type="bibr">47</xref>]</td><td rowspan="1" colspan="1">2007</td><td rowspan="1" colspan="1">Case series - Retrospective</td><td rowspan="1" colspan="1">Open TME with ANP</td><td rowspan="1" colspan="1">124</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile dysfunction: 37.7%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 42.9%</td></tr><tr><td rowspan="1" colspan="1">Akasu <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B43" ref-type="bibr">43</xref>]</td><td rowspan="1" colspan="1">2009</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">Open LAR/APR with selected ANP and PLND</td><td rowspan="1" colspan="1">66</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male erectile dysfunction (SD)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bilateral pelvic-plexus preservation without PLND: 5%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Bilateral pelvic-plexus preservation with PLND: 44%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Unilateral pelvic-plexus preservation with PLND: 55%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No pelvic-plexus preservation with PLND: 100%</td></tr><tr><td rowspan="1" colspan="1">Zhao <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B48" ref-type="bibr">48</xref>]</td><td rowspan="1" colspan="1">2011</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Open TME and ANP <italic>vs</italic> TME alone</td><td rowspan="1" colspan="1">84</td><td rowspan="1" colspan="1">Up to 24</td><td rowspan="1" colspan="1">Male erectile dysfunction: 29.3% in TME and ANP <italic>vs</italic> 76.7% in TME alone (SD)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 26.8% in TME and ANP <italic>vs</italic> 79.1% in TME alone (SD)</td></tr><tr><td rowspan="1" colspan="1">Cakabay <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B44" ref-type="bibr">44</xref>]</td><td rowspan="1" colspan="1">2012</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">TME</td><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile dysfunction: 5%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 10%</td></tr><tr><td rowspan="1" colspan="1"><bold>Laparoscopic/Robotic TME</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Quah <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B10" ref-type="bibr">10</xref>]</td><td rowspan="1" colspan="1">2002</td><td rowspan="1" colspan="1">Randomized controlled trial</td><td rowspan="1" colspan="1">Laparoscopic assisted <italic>vs</italic> open TME</td><td rowspan="1" colspan="1">80</td><td rowspan="1" colspan="1">Median 36</td><td rowspan="1" colspan="1">Sexual dysfunction (both sexes) 23.9% in laparoscopic <italic>vs</italic> 10.8% in open.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile dysfunction: 40% in laparoscopic <italic>vs</italic> 13.7% in open.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 40% in laparoscopic <italic>vs</italic> 4.6% in open.</td></tr><tr><td rowspan="1" colspan="1">Jayne <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B49" ref-type="bibr">49</xref>]</td><td rowspan="1" colspan="1">2005</td><td rowspan="1" colspan="1">Randomized controlled trial</td><td rowspan="1" colspan="1">Laparoscopic rectal <italic>vs</italic> open rectal <italic>vs</italic> laparoscopic colonic</td><td rowspan="1" colspan="1">246</td><td rowspan="1" colspan="1">Up to 76</td><td rowspan="1" colspan="1">Male sexual dysfunction: 41% in laparoscopic rectal, 23% in open rectal and 4% in laparoscopic colonic.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male erectile and ejaculatory dysfunction more common in laparoscopic and open rectal surgery but none in laparoscopic colonic.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female sexual dysfunction: 28% in laparoscopic rectal, 18% open rectal 18%, and 8% in laparoscopic colonic.</td></tr><tr><td rowspan="1" colspan="1">Liang <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B52" ref-type="bibr">52</xref>]</td><td rowspan="1" colspan="1">2007</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">Laparoscopic TME</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Male erectile dysfunction: 37.5%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 43.7%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female orgasmic dysfunction: 32.1%</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Female dyspareunia: 39.2%</td></tr><tr><td rowspan="1" colspan="1">Liu <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B63" ref-type="bibr">63</xref>]</td><td rowspan="1" colspan="1">2009</td><td rowspan="1" colspan="1">Randomized control trial</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> open TME with ANP</td><td rowspan="1" colspan="1">119</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male sexual dysfunction: 11.6% in laparoscopic <italic>vs</italic> 16.9% in open (no SD)</td></tr><tr><td rowspan="1" colspan="1">McGloen <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B50" ref-type="bibr">50</xref>]</td><td rowspan="1" colspan="1">2012</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> open TME</td><td rowspan="1" colspan="1">143</td><td rowspan="1" colspan="1">Minimal 6</td><td rowspan="1" colspan="1">Worse IIEF score in male open group, especially erectile function (SD).</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Worse FSFI score in female open group (SD).</td></tr><tr><td rowspan="1" colspan="1">Kim <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B54" ref-type="bibr">54</xref>]</td><td rowspan="1" colspan="1">2012</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> robotic TME</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male erectile dysfunction: 13.3% in robotic <italic>vs</italic> 12.8 % in laparoscopic (no SD)</td></tr><tr><td rowspan="1" colspan="1">D&#x02019;Annibale <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B55" ref-type="bibr">55</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> robotic TME</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male erectile dysfunction: 5.6% in robotic <italic>vs</italic> 57% in laparoscopic at 12 months(SD)</td></tr><tr><td rowspan="1" colspan="1">Luca <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B57" ref-type="bibr">57</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">Totally Robotic TME</td><td rowspan="1" colspan="1">74</td><td rowspan="1" colspan="1">17.03</td><td rowspan="1" colspan="1">No change in IIEF or FSFI score</td></tr><tr><td rowspan="1" colspan="1">Runkel <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B53" ref-type="bibr">53</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Case series - Prospective</td><td rowspan="1" colspan="1">Laparoscopic nerve orientated mesorectal excision</td><td rowspan="1" colspan="1">42</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male erectile dysfunction: 18.2%</td></tr><tr><td rowspan="1" colspan="1">Hur <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B51" ref-type="bibr">51</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Non-randomized control trial</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> open TME</td><td rowspan="1" colspan="1">50</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">Male sexual dysfunction: 22.7% in open <italic>vs</italic> 7.1% in laparoscopic.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">No significant change of IIEF score by 12 months in both groups.</td></tr><tr><td rowspan="1" colspan="1">Zeng <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B59" ref-type="bibr">59</xref>]</td><td rowspan="1" colspan="1">2013</td><td rowspan="1" colspan="1">Cohort study</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> open TME with ANP</td><td rowspan="1" colspan="1">81</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">Male erectile dysfunction: 27.91% in laparoscopic <italic>vs</italic> 28.95% in open (no SD).</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Male ejaculatory dysfunction: 25.58% in laparoscopic <italic>vs</italic> 23.68% in open (no SD).</td></tr><tr><td rowspan="1" colspan="1">Park <italic>et&#x000a0;al.</italic> [<xref rid="gow023-B56" ref-type="bibr">56</xref>]</td><td rowspan="1" colspan="1">2014</td><td rowspan="1" colspan="1">Case control</td><td rowspan="1" colspan="1">Laparoscopic <italic>vs</italic> robotic TME</td><td rowspan="1" colspan="1">64</td><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">IIEF Scores for robotic group higher at 6 months compared to laparoscopic group</td></tr></tbody></table><table-wrap-foot><fn id="gow023-TF2"><p>ANP: autonomic nerve preservation; PLND: pelvic lymph node dissection; SHP: superior hypogastric plexus; APR: abdominoperineal resection; LAR: low anterior resection; IIEF: International index of Erectile Function; FSFI: Female Sexual Function Index; SD: statistical significant difference</p></fn></table-wrap-foot></table-wrap></p><p>Post-laparoscopic TME results in 12.8% to 57% erectile dysfunction, 40% to 43.7% ejaculatory dysfunction and 7.1% to 41% overall male sexual dysfunction (<xref ref-type="table" rid="gow023-T2">Table 2</xref>) [<xref rid="gow023-B10" ref-type="bibr">10</xref>,<xref rid="gow023-B49" ref-type="bibr">49&#x02013;57</xref>,<xref rid="gow023-B59" ref-type="bibr">59</xref>,<xref rid="gow023-B63" ref-type="bibr">63</xref>]. When comparing the incidence of sexual dysfunction following laparoscopic TME with open TME, the benefit of minimally invasive surgery is inconsistent. Jayne <italic>et al</italic>. and Quah <italic>et al</italic>. randomized trials suggested worse sexual functioning in laparoscopic rectal surgery (23.9&#x02013;41%) compared with open surgery (10.8&#x02013;18%) [<xref rid="gow023-B10" ref-type="bibr">10</xref>,<xref rid="gow023-B49" ref-type="bibr">49</xref>]. However, Liu&#x02019;s randomized trial demonstrated lower incidence of sexual dysfunction in laparoscopic TME with ANP <italic>vs</italic> open procedure (11.6% <italic>vs</italic> 16.9%); it is worth noting that the result shows no statistical significance [<xref rid="gow023-B63" ref-type="bibr">63</xref>]. In a more recent cohort study and a non-randomized trial, there is no statistically significant difference in the incidence of both erectile and ejaculatory dysfunction among laparoscopic <italic>vs</italic> open TME [<xref rid="gow023-B51" ref-type="bibr">51</xref>,<xref rid="gow023-B56" ref-type="bibr">56</xref>], but one study noted worse functioning of both sexes in the open group [<xref rid="gow023-B50" ref-type="bibr">50</xref>]. When robotic surgery was compared with laparoscopic TME, Kim <italic>et&#x000a0;al<italic>.</italic></italic> and Park <italic>et&#x000a0;al<italic>.</italic></italic> noted no difference in function between both arms [<xref rid="gow023-B54" ref-type="bibr">54</xref>,<xref rid="gow023-B58" ref-type="bibr">58</xref>], but D&#x02019;Annibale <italic>et&#x000a0;al<italic>.</italic></italic> noted that while the erectile function worsened 1 month after surgery, it was almost completely restored at 12 months in the robotic group but only partially restored in the laparoscopic group with an incidence of 57% [<xref rid="gow023-B55" ref-type="bibr">55</xref>].</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>It is evident from this summary of outcomes that there is still more work to be done. It must be remembered that colorectal surgery underwent a huge wave of change in the time frame of the conducted studies. There was a radical shift from open to minimally invasive and robotic techniques, as well as a worldwide application of neoadjuvant chemoradiotherapy for locally advanced rectal cancers, which was all largely happening in the preceding 10&#x02013;15 years. Many of the cohort studies also appear to have strong selection bias and perhaps include many institutions&#x02019; learning curves for the minimally invasive techniques. In addition, many of these studies have a short follow up of &#x0003c;&#x000a0;2 years with a relatively small number of subjects. We must therefore interpret all study results cautiously. While open TME results initially appeared to have high urinary and sexual dysfunction rates, the later studies showed no differences in outcomes between laparoscopic and open techniques in terms of urinary dysfunction. There appeared to be worsened sexual functioning in the earlier studies for laparoscopic TME, but no difference was observed in the later studies. The argument of robotic technique also remains largely undecided with perhaps improved shorter-term urinary function within 3 months, but no difference in 12 months. There is no similar benefit for sexual function as well. It is important that successful rectal surgery be based not only on histopathological oncologic outcomes but also on the quality-of-life indices of every patient being restored to near normal as soon as possible. The decision about which technique to use will largely depend on a multitude of factors including tumour factors, pelvic anatomy and perhaps cost effectiveness. Nonetheless, regardless of the technique to be applied, the rectal surgeon must be aware of anatomical landmarks and hazards while dissecting to avoid nerve injury and make a dedicated attempt to preserve for autonomic nerve functioning.</p><p><italic>Conflict of interest statement</italic>: none declared.</p></sec></body><back><ref-list><title>References</title><ref id="gow023-B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokey</surname><given-names>EL</given-names></name><name><surname>Ojerskog</surname><given-names>B</given-names></name><name><surname>Chapuis</surname><given-names>PH</given-names></name><etal/></person-group>
<article-title>Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection</article-title>. <source>Br J Surg</source>
<year>1999</year>;<volume>86</volume>:<fpage>1164</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">10504371</pub-id></mixed-citation></ref><ref id="gow023-B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heald</surname><given-names>RJ</given-names></name><name><surname>Moran</surname><given-names>BJ</given-names></name><name><surname>Ryall</surname><given-names>RD</given-names></name><etal/></person-group>
<article-title>Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978 &#x02013; 1997</article-title>. <source>Arch Surg</source>
<year>1998</year>;<volume>133</volume>:<fpage>894</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">9711965</pub-id></mixed-citation></ref><ref id="gow023-B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braga</surname><given-names>M</given-names></name><name><surname>Frasson</surname><given-names>M</given-names></name><name><surname>Vignali</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis</article-title>. <source>Dis Colon Rectum</source>
<year>2007</year>;<volume>50</volume>:<fpage>464</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">17195085</pub-id></mixed-citation></ref><ref id="gow023-B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lujan</surname><given-names>J</given-names></name><name><surname>Valero</surname><given-names>G</given-names></name><name><surname>Hernandez</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer</article-title>. <source>Br J Surg</source>
<year>2009</year>;<volume>96</volume>:<fpage>982</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19644973</pub-id></mixed-citation></ref><ref id="gow023-B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vennix</surname><given-names>S</given-names></name><name><surname>Pelzers</surname><given-names>L</given-names></name><name><surname>Bouvy</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Laparoscopic versus open total mesorectal excision for rectal cancer</article-title>. <source>Cochrane Database Syst Rev</source>
<year>2014</year>;<volume>4</volume>:<fpage>CD005200</fpage>.<pub-id pub-id-type="pmid">24737031</pub-id></mixed-citation></ref><ref id="gow023-B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>SB</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Jeong</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial</article-title>. <source>Lancet Oncol</source>
<year>2010</year>;<volume>11</volume>:<fpage>637</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">20610322</pub-id></mixed-citation></ref><ref id="gow023-B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pigazzi</surname><given-names>A</given-names></name><name><surname>Luca</surname><given-names>F</given-names></name><name><surname>Patriti</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Multicentric study on robotic tumour-specific mesorectal excision for the treatment of rectal cancer</article-title>. <source>Am Surg Oncol</source>
<year>2010</year>;<volume>17</volume>:<fpage>1614</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="gow023-B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>deSouza</surname><given-names>AL</given-names></name><name><surname>Prasad</surname><given-names>LM</given-names></name><name><surname>Marecik</surname><given-names>SJ</given-names></name><etal/></person-group>
<article-title>Total mesorectal excision for rectal cancer: the potential advantage of robotic assistance</article-title>. <source>Dis Colon Rectum</source>
<year>2010</year>;<volume>53</volume>:<fpage>1611</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">21178854</pub-id></mixed-citation></ref><ref id="gow023-B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>JH</given-names></name><name><surname>Mc Kenzie</surname><given-names>S</given-names></name><name><surname>Garcia-Aguilar</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Oncologic outcomes of robotic-assisted total mesorectal excision of the treatment of rectal cancer</article-title>. <source>Ann Surg</source>
<year>2010</year>;<volume>251</volume>:<fpage>882</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">20395863</pub-id></mixed-citation></ref><ref id="gow023-B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quah</surname><given-names>HM</given-names></name><name><surname>Jayne</surname><given-names>DG</given-names></name><name><surname>Eu</surname><given-names>KW</given-names></name><etal/></person-group>
<article-title>Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer</article-title>. <source>Br J Surg</source>
<year>2002</year>;<volume>89</volume>:<fpage>1551</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">12445065</pub-id></mixed-citation></ref><ref id="gow023-B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>NK</given-names></name><name><surname>Aahn</surname><given-names>TW</given-names></name><name><surname>Park Lee</surname><given-names>KY</given-names></name><etal/></person-group>
<article-title>Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer</article-title>. <source>Dis Colon Rectum</source>
<year>2002</year>;<volume>45</volume>:<fpage>1178</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">12352233</pub-id></mixed-citation></ref><ref id="gow023-B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porcard</surname><given-names>M</given-names></name><name><surname>Zinzindohoue</surname><given-names>F</given-names></name><name><surname>Haab</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation after rectal cancer</article-title>. <source>Surgery</source>
<year>2002</year>;<volume>131</volume>:<fpage>368</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">11935125</pub-id></mixed-citation></ref><ref id="gow023-B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname><given-names>IR</given-names></name><name><surname>Woodward</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>FG</given-names></name><etal/></person-group>
<article-title>Female urogenital dysfunction following total mesorectal excision for rectal cancer</article-title>. <source>World J Surg Oncol</source>
<year>2006</year>;<volume>4</volume>:<fpage>6</fpage>.<pub-id pub-id-type="pmid">16448559</pub-id></mixed-citation></ref><ref id="gow023-B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>MM</given-names></name><name><surname>van de Velde</surname><given-names>CJ</given-names></name></person-group>
<article-title>Urinary and sexual dysfunction after rectal cancer treatment</article-title>. <source>Nat Rev Urol</source>
<year>2011</year>;<volume>8</volume>:<fpage>51</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">21135876</pub-id></mixed-citation></ref><ref id="gow023-B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moszkowicz</surname><given-names>D</given-names></name><name><surname>Alsaid</surname><given-names>B</given-names></name><name><surname>Bessede</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Where does pelvic nerve injury occur during rectal surgery for cancer?</article-title>. <source>Colorectal Dis</source>
<year>2011</year>;<volume>13</volume>:<fpage>1326</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">20718836</pub-id></mixed-citation></ref><ref id="gow023-B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bissett</surname><given-names>IP</given-names></name><name><surname>Hill</surname><given-names>GL</given-names></name></person-group>
<article-title>Extrafascial excision of the rectum for cancer: a technique for the avoidance for the complications of rectal mobilization</article-title>. <source>Semin Surg Oncol</source>
<year>2000</year>;<volume>18</volume>:<fpage>207</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">10757886</pub-id></mixed-citation></ref><ref id="gow023-B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>YQ</given-names></name><name><surname>Chang</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Clinical anatomy study of autonomic nerve with respective to the anterior approach lumbar surgery</article-title>. <source>Surg Radiol Anat</source>
<year>2009</year>;<volume>31</volume>:<fpage>425</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">19190849</pub-id></mixed-citation></ref><ref id="gow023-B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauroy</surname><given-names>B</given-names></name><name><surname>Demondion</surname><given-names>X</given-names></name><name><surname>Bizet</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>The female inferior hypogastric (=pelvic) plexus: anatomical and radiological description of the plexus and its afferences&#x02013; applications to pelvic surgery</article-title>. <source>Surg Radiol Anat</source>
<year>2007</year>;<volume>29</volume>:<fpage>55</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">17186314</pub-id></mixed-citation></ref><ref id="gow023-B19"><label>19</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Masaro</surname><given-names>S</given-names></name><name><surname>Palmissano</surname><given-names>S</given-names></name><name><surname>Leon</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Nerve sparing technique in rectal cancer</article-title>. In: <person-group person-group-type="editor"><name><surname>N</surname><given-names>de Manzini</given-names></name></person-group> (ed). <source>Rectal Cancer: Strategy and Surgical Techniques (Updates in Surgery)</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>,<year>2013</year>,<fpage>107</fpage>&#x02013;<lpage>15</lpage>.</mixed-citation></ref><ref id="gow023-B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamopoulos</surname><given-names>P</given-names></name><name><surname>Theodoropoulos</surname><given-names>GE</given-names></name><name><surname>Papailiou</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Prospective evaluation of sexual function after open and laparoscopic surgery for rectal cancer</article-title>. <source>Surg Endosc</source>
<year>2009</year>;<volume>23</volume>:<fpage>2665</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">19466496</pub-id></mixed-citation></ref><ref id="gow023-B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bissett</surname><given-names>IP</given-names></name><name><surname>Zarkovic</surname></name><name><surname>Hamilton</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Localisation of hypogastric nerves and pelvic plexus in relation to rectal cancer surgery</article-title>. <source>Eur J Anat</source>
<year>2007</year>;<volume>11</volume>:<fpage>111</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="gow023-B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>OM</given-names></name><name><surname>Smeulders</surname><given-names>N</given-names></name><name><surname>Wiseman</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Lateral ligaments of the rectum: an anatomical study</article-title>. <source>Br J Surg</source>
<year>1999</year>;<volume>86</volume>:<fpage>487</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">10215819</pub-id></mixed-citation></ref><ref id="gow023-B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutegard</surname><given-names>J</given-names></name><name><surname>Sandzen</surname><given-names>B</given-names></name><name><surname>Stenling</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Lateral rectal ligament contain important nerves</article-title>. <source>Br J Surg</source>
<year>1997</year>;<volume>84</volume>:<fpage>1544</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">9393275</pub-id></mixed-citation></ref><ref id="gow023-B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name></person-group>
<article-title>The vascular and neuronal composition of the lateral ligament of the rectum and rectosacral fascia</article-title>. <source>Surg Radiol Anat</source>
<year>1991</year>;<volume>13</volume>:<fpage>17</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">2053040</pub-id></mixed-citation></ref><ref id="gow023-B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagpal</surname><given-names>K</given-names></name><name><surname>Bennett</surname><given-names>N</given-names></name></person-group>
<article-title>Colorectal surgery and its impact on male sexual function</article-title>. <source>Curr Urol Rep</source>
<year>2013</year>;<volume>14</volume>:<fpage>279</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">23716030</pub-id></mixed-citation></ref><ref id="gow023-B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grama</surname><given-names>FA</given-names></name><name><surname>Burco</surname><given-names>T</given-names></name><name><surname>Bordea</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Localisation and preservation of the autonomic nerves in rectal cancer surgery - technical details</article-title>. <source>Chirurgia (Bucur)</source>
<year>2014</year>;<volume>109</volume>:<fpage>375</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">24956344</pub-id></mixed-citation></ref><ref id="gow023-B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsey</surname><given-names>I</given-names></name><name><surname>Guy</surname><given-names>RJ</given-names></name><name><surname>Warren</surname><given-names>BF</given-names></name><etal/></person-group>
<article-title>Anatomy of Denonvilliers&#x02019; fascia and pelvic nerves, impotence, and implications for the colorectal surgeon</article-title>. <source>Br J Surg</source>
<year>2000</year>;<volume>87</volume>:<fpage>1288</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">11044153</pub-id></mixed-citation></ref><ref id="gow023-B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsey</surname><given-names>I</given-names></name><name><surname>Mortensen</surname><given-names>NJ</given-names></name></person-group>
<article-title>Iatrogenic impotence and rectal dissection</article-title>. <source>Br J Surg</source>
<year>2002</year>;<volume>89</volume>:<fpage>1493</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">12445056</pub-id></mixed-citation></ref><ref id="gow023-B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Havenga</surname><given-names>K</given-names></name><name><surname>Enker</surname><given-names>WE</given-names></name><name><surname>McDermott</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum</article-title>. <source>J Am Coll Surg</source>
<year>1996</year>;<volume>182</volume>:<fpage>495</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="pmid">8646349</pub-id></mixed-citation></ref><ref id="gow023-B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hojo</surname><given-names>K</given-names></name><name><surname>Vernava</surname><given-names>AM</given-names><suffix>3rd</suffix></name><name><surname>Sugihara</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Preservation of urine voiding and sexual function after rectal cancer surgery</article-title>. <source>Dis Colon Rectum</source>
<year>1991</year>;<volume>34</volume>:<fpage>532</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">2055138</pub-id></mixed-citation></ref><ref id="gow023-B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugihara</surname><given-names>K</given-names></name><name><surname>Moriya</surname><given-names>Y</given-names></name><name><surname>Akasu</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome</article-title>. <source>Cancer</source>
<year>1996</year>;<volume>78</volume>:<fpage>1871</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">8909305</pub-id></mixed-citation></ref><ref id="gow023-B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>N</given-names></name><name><surname>Sarashina</surname><given-names>H</given-names></name><name><surname>Nunomura</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Clinical evaluation of nerve-sparing surgery combined with preoperative radiotherapy in advanced rectal cancer patients</article-title>. <source>Am J Surg</source>
<year>1998</year>;<volume>175</volume>:<fpage>277</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">9568651</pub-id></mixed-citation></ref><ref id="gow023-B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikura</surname><given-names>S</given-names></name><name><surname>Ogino</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Preliminary results of pelvic autonomic nerve-preserving surgery combined with intraoperative and postoperative radiation therapy for patients with low rectal cancer</article-title>. <source>Jpn J Clin Oncol</source>
<year>1999</year>;<volume>29</volume>:<fpage>429</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">10563196</pub-id></mixed-citation></ref><ref id="gow023-B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesbakken</surname><given-names>A</given-names></name><name><surname>Nygaard</surname><given-names>K</given-names></name><name><surname>Bull-Njaa</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Bladder and sexual dysfunction after mesorectal excision for rectal cancer</article-title>. <source>Br J Surg</source>
<year>2000</year>;<volume>87</volume>:<fpage>206</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">10671929</pub-id></mixed-citation></ref><ref id="gow023-B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maas</surname><given-names>CP</given-names></name><name><surname>Moriya</surname><given-names>Y</given-names></name><name><surname>Steup</surname><given-names>WH</given-names></name><etal/></person-group>
<article-title>A prospective study on radical and nerve-preserving surgery for rectal cancer in the Netherlands</article-title>. <source>Eur J Surg Oncol</source>
<year>2000</year>;<volume>26</volume>:<fpage>751</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">11087640</pub-id></mixed-citation></ref><ref id="gow023-B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurer</surname><given-names>CA</given-names></name><name><surname>Z&#x02019;Graggen</surname><given-names>K</given-names></name><name><surname>Renzulli</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery</article-title>. <source>Br J Surg</source>
<year>2001</year>;<volume>88</volume>:<fpage>1501</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">11683749</pub-id></mixed-citation></ref><ref id="gow023-B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kneist</surname><given-names>W</given-names></name><name><surname>Heintz</surname><given-names>A</given-names></name><name><surname>Junginger</surname><given-names>T</given-names></name></person-group>
<article-title>Intraoperative identification and neurophysiologic parameters to verify pelvic autonomic nerve function during total mesorectal excision for rectal cancer</article-title>. <source>J Am Coll Surg</source>
<year>2004</year>;<volume>198</volume>:<fpage>59</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">14698312</pub-id></mixed-citation></ref><ref id="gow023-B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junginger</surname><given-names>T</given-names></name><name><surname>Kneist</surname><given-names>W</given-names></name><name><surname>Heintz</surname><given-names>A</given-names></name></person-group>
<article-title>Influence of identification and preservation of pelvic autonomic nerves in rectal cancer surgery on bladder dysfunction after total mesorectal excision</article-title>. <source>Dis Colon Rectum</source>
<year>2003</year>;<volume>46</volume>:<fpage>621</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">12792438</pub-id></mixed-citation></ref><ref id="gow023-B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sterk</surname><given-names>P</given-names></name><name><surname>Shekarriz</surname><given-names>B</given-names></name><name><surname>G&#x000fc;nter</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients</article-title>. <source>Int J Colorectal Dis</source>
<year>2005</year>;<volume>20</volume>:<fpage>423</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">15846498</pub-id></mixed-citation></ref><ref id="gow023-B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirouzu</surname><given-names>K</given-names></name><name><surname>Ogata</surname><given-names>Y</given-names></name><name><surname>Araki</surname><given-names>Y</given-names></name></person-group>
<article-title>Oncologic and functional results of total mesorectal excision and autonomic nerve-preserving operation for advanced lower rectal cancer</article-title>. <source>Dis Colon Rectum</source>
<year>2004</year>;<volume>47</volume>:<fpage>1442</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">15486739</pub-id></mixed-citation></ref><ref id="gow023-B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyo</surname><given-names>K</given-names></name><name><surname>Sameshima</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer</article-title>. <source>World J Surg</source>
<year>2006</year>;<volume>30</volume>:<fpage>1014</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16736330</pub-id></mixed-citation></ref><ref id="gow023-B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kneist</surname><given-names>W</given-names></name><name><surname>Junginger</surname><given-names>T</given-names></name></person-group>
<article-title>Long-term urinary dysfunction after mesorectal excision: a prospective study with intraoperative electrophysiological confirmation of nerve preservation</article-title>. <source>Eur J Surg Oncol</source>
<year>2007</year>;<volume>33</volume>:<fpage>1068</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">17524598</pub-id></mixed-citation></ref><ref id="gow023-B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akasu</surname><given-names>T</given-names></name><name><surname>Sugihara</surname><given-names>K</given-names></name><name><surname>Moriya</surname><given-names>Y</given-names></name></person-group>
<article-title>Male urinary and sexual functions after mesorectal excision alone or in combination with extended lateral pelvic lymph node dissection for rectal cancer</article-title>. <source>Ann Surg Oncol</source>
<year>2009</year>;<volume>16</volume>:<fpage>2779</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">19626377</pub-id></mixed-citation></ref><ref id="gow023-B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cakabay</surname><given-names>B</given-names></name><name><surname>Aksel</surname><given-names>B</given-names></name><name><surname>Derirci</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Male sexual and urinary function after total mesorectal excision</article-title>. <source>EJSS</source>
<year>2012</year>;<volume>3</volume>:<fpage>46</fpage>&#x02013;<lpage>50</lpage>.</mixed-citation></ref><ref id="gow023-B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JP</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>XM</given-names></name><etal/></person-group>
<article-title>Pelvic autonomic nerve preservation in 96 female patients of rectal carcinoma undergoing radical resection</article-title>. <source>Chin J Gen Surg</source>
<year>2005</year>;<volume>20</volume>:<fpage>619</fpage>&#x02013;<lpage>21</lpage>.</mixed-citation></ref><ref id="gow023-B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Autonomic nerve preserving radical operation for rectal cancer patients</article-title>. <source>Chin J Gen Surg</source>
<year>2006</year>;<volume>21</volume>:<fpage>511</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="gow023-B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>XS</given-names></name><name><surname>Xu</surname><given-names>HT</given-names></name><name><surname>Li</surname><given-names>ZG</given-names></name><etal/></person-group>
<article-title>Effect of lateral lymph nodes dissection and autonomic nerve preservation in anterior resection for rectal cancer: 124 cases review [in Chinese]</article-title>. <source>Chin J Surg</source>
<year>2007</year>;<volume>45</volume>:<fpage>1164</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">18067706</pub-id></mixed-citation></ref><ref id="gow023-B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>PY</given-names></name></person-group>
<article-title>Effect of Pelvic autonomic nerve preservation with total mesorectal excision on sexual and urinary function in male rectal cancer patients</article-title>. <source>Chin J Bases Clin General Surg</source>
<year>2011</year>;<volume>18</volume>:<fpage>191</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="gow023-B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayne</surname><given-names>DG</given-names></name><name><surname>Brown</surname><given-names>JM</given-names></name><name><surname>Thorpe</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique</article-title>. <source>Br J Surg</source>
<year>2005</year>;<volume>92</volume>:<fpage>1124</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">15997446</pub-id></mixed-citation></ref><ref id="gow023-B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGlone</surname><given-names>ER</given-names></name><name><surname>Khan</surname><given-names>O</given-names></name><name><surname>Flashman</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Urogenital function following laparoscopic and open rectal cancer resection: a comparative study</article-title>. <source>Surg Endosc</source>
<year>2012</year>;<volume>26</volume>:<fpage>2559</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">22476834</pub-id></mixed-citation></ref><ref id="gow023-B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hur</surname><given-names>H</given-names></name><name><surname>Bae</surname><given-names>SU</given-names></name><name><surname>Kim</surname><given-names>NK</given-names></name><etal/></person-group>
<article-title>Comparative study of voiding and male sexual function following open and laparoscopic total mesorectal excision in patients with rectal cancer</article-title>. <source>J Surg Oncol</source>
<year>2013</year>;<volume>108</volume>:<fpage>572</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">24115080</pub-id></mixed-citation></ref><ref id="gow023-B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>JT</given-names></name><name><surname>Lai</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>PH</given-names></name></person-group>
<article-title>Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy</article-title>. <source>Ann Surg Oncol</source>
<year>2007</year>;<volume>14</volume>:<fpage>1285</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">17235719</pub-id></mixed-citation></ref><ref id="gow023-B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runkel</surname><given-names>N</given-names></name><name><surname>Reiser</surname><given-names>H</given-names></name></person-group>
<article-title>Nerve-oriented mesorectal excision (NOME): autonomic nerves as landmarks for laparoscopic rectal resection</article-title>. <source>Int J Colorectal Dis</source>
<year>2013</year>;<volume>28</volume>:<fpage>1367</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="pmid">23666512</pub-id></mixed-citation></ref><ref id="gow023-B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>NK</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><etal/></person-group>
<article-title>A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery</article-title>. <source>Ann Surg Oncol</source>
<year>2012</year>;<volume>19</volume>:<fpage>2485</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">22434245</pub-id></mixed-citation></ref><ref id="gow023-B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Annibale</surname><given-names>A</given-names></name><name><surname>Pernazza</surname><given-names>G</given-names></name><name><surname>Monsellato</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer</article-title>. <source>Surg Endosc</source>
<year>2013</year>;<volume>27</volume>:<fpage>1887</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">23292566</pub-id></mixed-citation></ref><ref id="gow023-B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Choi</surname><given-names>GS</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title>Urinary and erectile function in men after total mesorectal excision by laparoscopic or robotic assisted methods for the treatment of rectal cancer: a case-matched comparison</article-title>. <source>World J Surg</source>
<year>2014</year>;<volume>38</volume>:<fpage>1834</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="pmid">24366278</pub-id></mixed-citation></ref><ref id="gow023-B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luca</surname><given-names>F</given-names></name><name><surname>Valvo</surname><given-names>M</given-names></name><name><surname>Ghezzi</surname><given-names>TL</given-names></name><etal/></person-group>
<article-title>Impact of robotic surgery on sexual and urinary functions after fully robotic nerve-sparing total mesorectal excision for rectal cancer</article-title>. <source>Ann Surg</source>
<year>2013</year>;<volume>257</volume>:<fpage>672</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">23001075</pub-id></mixed-citation></ref><ref id="gow023-B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enker</surname><given-names>WE</given-names></name><name><surname>Havenga</surname><given-names>K</given-names></name><name><surname>Polyak</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer</article-title>. <source>World J Surg</source>
<year>1997</year>;<volume>21</volume>:<fpage>715</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">9276702</pub-id></mixed-citation></ref><ref id="gow023-B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>ZQ</given-names></name><name><surname>Huo</surname><given-names>JS</given-names></name><name><surname>Tao</surname><given-names>SM</given-names></name></person-group>
<article-title>Study on of sex and urination functions of male rectal cancer patients after pelvic autonomic nerve-preserving total mesorectal excision: laparoscopic resection versus open resection</article-title>. <source>Chin J Gen Surg</source>
<year>2013</year>;<volume>22</volume>:<fpage>800</fpage>&#x02013;<lpage>2</lpage>.</mixed-citation></ref><ref id="gow023-B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JP</given-names></name><name><surname>Yang</surname><given-names>Zl</given-names></name><name><surname>Tang</surname><given-names>YZ</given-names></name><etal/></person-group>
<article-title>Effects of pelvic autonomic nerve preservation on male patients with rectal cancer</article-title>. <source>Chin J Pract Surg</source>
<year>2003</year>;<volume>23</volume>:<fpage>46</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="gow023-B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JP</given-names></name><name><surname>Cai</surname><given-names>GF</given-names></name><name><surname>Huang</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>Influence of surgeon-related factors on postoperative sexual function in patients with rectal cancer</article-title>. <source>Chin J Pract Surg</source>
<year>2005</year>;<volume>25</volume>:<fpage>52</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="gow023-B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JP</given-names></name><name><surname>Huang</surname><given-names>MJ</given-names></name><name><surname>Song</surname><given-names>XM</given-names></name><etal/></person-group>
<article-title>The assessment of curative effect after total mesorectal excision with autonomic nerve preservation for rectal cancer</article-title>. <source>Chin J Surg</source>
<year>2005</year>;<volume>43</volume>:<fpage>1500</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">16412282</pub-id></mixed-citation></ref><ref id="gow023-B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>LY</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>PW</given-names></name><etal/></person-group>
<article-title>Male sexual function after D(3) lymphadenectomy combined with pelvic autonomic nerve preservation by laparoscopic and open surgery for rectal cancer [in Chinese]</article-title>. <source>Chin J Gastrointest Surg</source>
<year>2009</year>;<volume>12</volume>:<fpage>236</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref></ref-list></back></article>